TipRanks
Go Ultimate55% OFF

Cellbion Co., Ltd (308430) Price & Analysis

308430 Stock Chart & Stats

₩11,670.00-₩1,050.00(-8.25%)
At close: 4:00 PM EDT
KRW 12,500KRW 15,0003 Aug18 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
KRW 11,410.00 - KRW 12,340.00
52-Week Range
KRW 9,930.00 - KRW 42,200.00
Previous Close
KRW 12,720.00
Volume
N/A
Average Volume (3M)
27.33K
Market Cap
KRW 150.60B
Enterprise Value
KRW 197.00B
Total Cash (Recent Filing)
N/A
Total Debt (Recent Filing)
N/A
Price to Earnings (P/E)
19.4
Beta
0.29
Next Earnings
Nov 12, 2026
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

308430 FAQ

What was Cellbion Co., Ltd’s price range in the past 12 months?
Cellbion Co., Ltd lowest stock price was ₩9930.00 and its highest was ₩42200.00 in the past 12 months.
What is Cellbion Co., Ltd’s market cap?
Cellbion Co., Ltd’s market cap is ₩150.60B.
When is Cellbion Co., Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cellbion Co., Ltd’s earnings last quarter?
Cellbion Co., Ltd released its earnings results on Aug 13, 2026. The company reported ₩1,118.5 earnings per share for the quarter.
Is Cellbion Co., Ltd overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Cellbion Co., Ltd pay dividends?
Cellbion Co., Ltd does not currently pay dividends.
What is Cellbion Co., Ltd’s EPS estimate?
Cellbion Co., Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cellbion Co., Ltd have?
Cellbion Co., Ltd has 12,905,251 shares outstanding.
What happened to Cellbion Co., Ltd’s price movement after its last earnings report?
Cellbion Co., Ltd reported an EPS of ₩1,118.5 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cellbion Co., Ltd?
Currently, no hedge funds are holding shares in KR:308430
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology